🔎 Trials Near Me

Akèy › Neyofibòm Plexifòm

Etid klinik pou Neyofibòm Plexifòm ap rekrite nan Etazini

8 etid pou Neyofibòm Plexifòm ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 5 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02544022

Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)

Ap rekriteEtid obsèvasyon
Laj 3 a 120 · Tout sèks · Mizajou Sep 2, 2026 · NCT06222203

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Ap rekriteFaz 1
Laj 16 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06502171

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06541847

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Ap rekriteFaz 2
Laj 1 a 8 · Tout sèks · Mizajou May 29, 2026 · NCT06188741

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Dec 4, 2025 · NCT06961565

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.